Jim Alecxih has more than 30 years of experience in all aspects of business, focused primarily on biotechnology and medical devices. His expertise includes product development and launch, as well as highly successful international and domestic go-to-market strategies.
Jim is President, Device Technology, for TriSalus Life Sciences, an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. He is responsible for overseeing the growth and development of TriSalus’ TriNav® Infusion System, including device engineering, quality, sales, marketing, and market access.
Prior to joining TriSalus, Jim served as President and CEO at ViveBio Scientific, a biotechnology company focused on specimen transportation and storage, where he raised funding to enable regulatory clearance, manufacturing, and commercialization of a propriety blood plasma separation device. As Chief Commercial Officer of ViewRay, an early-stage radiation oncology company, he led all commercial strategies. Jim spent most of his professional career at Intuitive Surgical, known for their minimally invasive da Vinci surgical systems, where he led successful domestic and international sales teams and exceeded revenue budgets for 51 consecutive quarters over a 14-year period, enabling significant revenue growth for the company.
Jim earned his BA in business administration from LeTourneau University in Longview, Texas.
